Cargando…
Patient evaluation of the use of follitropin alfa in a prefilled ready-to-use injection pen in assisted reproductive technology: an observational study
BACKGROUND: Self-administration of recombinant human follicle-stimulating hormone (r-hFSH) can be performed using injection pen devices by women undergoing assisted reproductive technology procedures. The objective of this study was to explore the use of the prefilled follitropin alfa pen in routine...
Autores principales: | Welcker, J Thomas, Nawroth, Frank, Bilger, Wilma |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2949697/ https://www.ncbi.nlm.nih.gov/pubmed/20843323 http://dx.doi.org/10.1186/1477-7827-8-111 |
Ejemplares similares
-
Managing infertility with the follitropin alfa prefilled pen injector – patient considerations
por: Bühler, Klaus
Publicado: (2015) -
Multicenter, noninterventional, post-marketing surveillance study to evaluate dosing of recombinant human follicle-stimulating hormone using the redesigned follitropin alfa pen in women undergoing ovulation induction
por: Nawroth, Frank, et al.
Publicado: (2015) -
A large, multicentre, observational, post-marketing surveillance study of the 2:1 formulation of follitropin alfa and lutropin alfa in routine clinical practice for assisted reproductive technology
por: Bühler, Klaus, et al.
Publicado: (2014) -
Human factors engineering and design validation for the redesigned follitropin alfa pen injection device
por: Mahony, Mary C, et al.
Publicado: (2015) -
Single-arm, observational study of the ease of use of a redesigned pen device to deliver recombinant human follicle-stimulating hormone (follitropin alfa) for assisted reproductive technology treatment
por: Illingworth, Peter J, et al.
Publicado: (2014)